NxStage Medical, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 81   

Articles published

NXTM 15.16 -2.51 (-14.20%)
price chart
Why NxStage Medical, Inc. Guided Lower Today
What: NxStage Medical (NASDAQ:NXTM) is down 14% near the closing bell after releasing disappointing guidance during its fourth-quarter earnings release this morning.
Insider Trading: Joseph Turk Sold 2500 Shares of NxStage Medical, Inc ...  fdanewsalert.com
NxStage Medical Inc.: NxStage Reports Record Fourth Quarter and Full-Year 2015 ...
NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today reported record revenue for the fourth quarter and fiscal year ended December 31, 2015, topping its recent upwardly revised revenue ...
Stock's Earnings Analysis Report: NxStage Medical, Inc. (NXTM)
NxStage Medical, Inc. (NASDAQ:NXTM) is expected to report 4th quarter earnings before the open on Feb 10, 2016, with a conference call scheduled for 9:00AM EST.
Joseph E. Turk, Jr. Sells 991 Shares of NxStage Medical, Inc. (NXTM) Stock  Financial Market News
Earnings Per Share Preview for NxStage Medical, Inc. (NXTM)  WallStreet.org
NxStage Medical, Inc. (NASDAQ:NXTM) Growth Company
Zacks Research has specified a positive Growth Style score to NxStage Medical, Inc. (NASDAQ:NXTM) by strong financial background and higher growth prospects.
Earnings Estimates For NxStage Medical, Inc. (NASDAQ:NXTM)
NxStage Medical, Inc. (NASDAQ:NXTM) stock settled during the last trading session at 18.00. It touched a high price of 18.06 and a low of 17.13 in current trading session.
NxStage Medical, Inc. (NXTM) Set to Announce Earnings on Wednesday
NxStage Medical logo NxStage Medical, Inc. (NASDAQ:NXTM) will release its Q415 earnings data on Wednesday, February 10th.
NxStage Medical, Inc. (NXTM) President Joseph E. Turk, Jr. Sells 991 Shares ...  Intercooler Financial
Analysts Set NxStage Medical, Inc. (NASDAQ:NXTM) Target Price at $27.25  Daily Political
Joseph Turk Insider Transaction for 991 Shares of NxStage Medical, Inc ...
Joseph Turk, the President of Nxstage Medical Inc, made a sale of 991 shares of the company, worth roughly $19,424 U.S. Dollars, based on $19.6 per share.
NxStage Medical, Inc. (NASDAQ:NXTM) Given Consensus Rating of "Buy" ...  Financial Market News
Wall Street Has $24 Price Target on NxStage Medical, Inc. (NASDAQ:NXTM)  Markets Daily
Nxstage Medical, Inc Bearish Trade. Feinberg Larry N decreased Its Position
Feinberg Larry N filed with SEC a SC 13G/A form about Nxstage Medical, Inc. The form can be accessed here: 000089914016001053.
NxStage Medical, Inc. (NXTM) SVP Winifred L. Swan Sells 620 Shares of Stock
NxStage Medical logo NxStage Medical, Inc. (NASDAQ:NXTM) SVP Winifred L. Swan sold 620 shares of the stock in a transaction that occurred on Thursday, January 14th.
Analyst Review Alert: NxStage Medical, Inc.  iStreetWire
Joseph E. Turk, Jr. Sells 1500 Shares of NxStage Medical, Inc. (NXTM) Stock
NxStage Medical logo NxStage Medical, Inc. (NASDAQ:NXTM) President Joseph E. Turk, Jr. sold 1,500 shares of the firm's stock in a transaction dated Friday, January 8th.
NxStage Medical, Inc. (NXTM) President Sells $77156.14 in Stock  Corvus Business Newswire
Matthew W. Towse Sells 3472 Shares of NxStage Medical, Inc. (NXTM) Stock  Zolmax